USPTO serial 79139817
MAGLUMI
Reviewed by CopyMark Law Group
Reg. 4683169Status 706Registered
- Filing date
- Status date
- Registration date
- Feb 10, 2015
- Examiner
- BRADLEY, EVELYN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with MAGLUMI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Guangdong, CN
Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Guangdong, CN
Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Shenzhen, Guangdong, CN
Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nazly Aileen Bayramoglu
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC1540 West Warm Springs Road, Suite 100Henderson, NV 89014United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drugs for medical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin disease; medicated serums for invitro diagnosis and treatment; medicated serums for in-vivo diagnosis and treatment; serotherapeutic medicines; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; chemical preparations for pharmaceutical purposes, namely, for diagnosis or treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposes, namely, for diagnosing or detecting tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy | ACTIVE | — |
| 010 | Blood testing apparatus; [ massage apparatus; ] apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples; testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer for analyzing blood samples, body fluids and body tissue samples; radiotherapy apparatus; ultrasonic devices and parts thereof for medical use, namely, clinical ultrasonic diagnostic apparatus and parts thereof [ ; artificial limbs; multifunction corsets for medical purpose, namely, diagnosis and therapeutic corsets for medical purpose; suture materials ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
- Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
- Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named MAGLUMI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 27, 2026 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Apr 2, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 19, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 19, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 19, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| May 19, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 24, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Feb 10, 2024 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| May 12, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 12, 2023 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 22, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 22, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 2, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 2, 2022 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 2, 2022 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Nov 19, 2021 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Oct 27, 2021 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Oct 25, 2021 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Oct 25, 2021 | REIN | REINSTATED | — |
| Oct 16, 2021 | NC71 | NOTICE OF CANCELLATION SEC. 71 E-MAILED | — |
| Oct 15, 2021 | C71T | CANCELLED SECTION 71 | — |
| Mar 11, 2021 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Mar 4, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 7, 2021 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Feb 20, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 26, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 27, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 11, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 11, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 10, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 10, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 13, 2015 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jan 3, 2015 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 25, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 5, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 23, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 22, 2014 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 22, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 22, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 22, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 14, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 27, 2014 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 26, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 17, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 17, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 8, 2014 | ALIE | ASSIGNED TO LIE | — |
| Mar 28, 2014 | ALIE | ASSIGNED TO LIE | — |
| Mar 17, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 30, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 30, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 21, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 20, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 14, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 14, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 12, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |